Perrigo Company PLC は1株あたり年間配当金が 1.1623 で、利回りは 10.6279% です。配当金は 四半期ごと に支払われ、最後の除息日は May 29, 2026 でした。
配当利回り
年間配当
除権日
10.6279%
$1.1623
May 29, 2026
支払い頻度
支払率
四半期ごと
532.00%
配当履歴
除権日
現金額
記録日
支払日
May 29, 2026
$0.29
May 29, 2026
Jun 16, 2026
Mar 2, 2026
$0.29
Mar 2, 2026
Mar 24, 2026
Nov 28, 2025
$0.29
Nov 28, 2025
Dec 16, 2025
Aug 29, 2025
$0.29
Aug 29, 2025
Sep 16, 2025
May 30, 2025
$0.29
May 30, 2025
Jun 17, 2025
Mar 7, 2025
$0.29
Mar 7, 2025
Mar 25, 2025
配当チャート
PRGO 配当
PRGO 配当成長率(年間比)
Follow-Up Questions
Perrigo Company PLCの現在の配当金と年間配当金はいくらですか?
Perrigo Company PLCが現在支払う配当金は$0.29です。Perrigo Company PLCの年間配当金は$1.1623です。
Perrigo Company PLCの配当性向は何ですか?
Perrigo Company PLCの配当性向は532.00%です。
PRGOの配当落ち日はいつですか?
Perrigo Company PLCの配当落ち日はMay 29, 2026です。
Perrigo Company PLCはどのくらいの頻度で配当金を支払いますか?
四半期ごと。Perrigo Company PLCが最後に配当金を支払ったのはJun 16, 2026です。
主要データ
前終値
$9.6
始値
$9.66
当日レンジ
$9.39 - $9.76
52週レンジ
$9.22 - $28.43
取引高
--
平均取引高
3.1M
配当利回り
10.63%
1株当たり利益(TTM)
-13.19
時価総額
$1.3B
PRGOとは何ですか?
Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.